Publications
- Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis2020 | First Faculty of Medicine
- Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients2015 | First Faculty of Medicine
- Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study2014 | First Faculty of Medicine
- Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromes2013 | First Faculty of Medicine
- Lipid profiles are associated with lesion formation over 24 months in interferon-beta treated patients following the first demyelinating event2013 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis2023 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis2021 | First Faculty of Medicine
Loading network view...